株価純利益率 (P/E)
2012年以降
計算
AbbVie Inc.、 P/E、長期トレンド計算
| P/E | = | 株価1, 2, 3 | ÷ | 1株当たり利益1 (EPS) | EPS1 | = | アッヴィに帰属する当期純利益1 (数百万単位) |
÷ | 発行済普通株式数2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025/02/14 | 79.59 | = | 192.87 | ÷ | 2.42 | 2.42 | = | 4,278 | ÷ | 1,765,354,859 | |
| 2024/02/20 | 63.84 | = | 175.75 | ÷ | 2.75 | 2.75 | = | 4,863 | ÷ | 1,766,473,359 | |
| 2023/02/17 | 22.62 | = | 151.31 | ÷ | 6.69 | 6.69 | = | 11,836 | ÷ | 1,769,399,971 | |
| 2022/02/18 | 22.07 | = | 144.03 | ÷ | 6.53 | 6.53 | = | 11,542 | ÷ | 1,768,753,829 | |
| 2021/02/19 | 40.17 | = | 105.01 | ÷ | 2.61 | 2.61 | = | 4,616 | ÷ | 1,765,881,690 | |
| 2020/02/21 | 17.82 | = | 94.96 | ÷ | 5.33 | 5.33 | = | 7,882 | ÷ | 1,479,156,683 | |
| 2019/02/27 | 20.60 | = | 79.41 | ÷ | 3.86 | 3.86 | = | 5,687 | ÷ | 1,475,083,514 | |
| 2018/02/16 | 35.47 | = | 118.60 | ÷ | 3.34 | 3.34 | = | 5,309 | ÷ | 1,587,972,655 | |
| 2017/02/17 | 16.54 | = | 61.77 | ÷ | 3.73 | 3.73 | = | 5,953 | ÷ | 1,593,920,285 | |
| 2016/02/19 | 17.01 | = | 54.29 | ÷ | 3.19 | 3.19 | = | 5,144 | ÷ | 1,611,238,226 | |
| 2015/02/20 | 55.08 | = | 61.30 | ÷ | 1.11 | 1.11 | = | 1,774 | ÷ | 1,593,886,909 | |
| 2014/02/21 | 19.64 | = | 51.04 | ÷ | 2.60 | 2.60 | = | 4,128 | ÷ | 1,588,518,764 | |
| 2013/03/15 | 11.51 | = | 38.50 | ÷ | 3.34 | 3.34 | = | 5,275 | ÷ | 1,577,334,090 |
レポートに基づく: 10-K (報告日: 2024-12-31), 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31).
1 米ドル
2 分割と株式配当の調整済みデータ。
3 AbbVie Inc.アニュアルレポート提出日時点の終値
競合他社との比較
AbbVie Inc.、 P/E、長期トレンド、競合他社との比較
| AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025/02/14 | 79.59 | 38.24 | — | 38.12 | 77.63 | 296.57 | 26.92 | 13.49 | 18.42 | 17.76 | 32.03 | — |
| 2024/02/20 | 63.84 | 23.14 | 12.27 | 39.09 | 135.24 | 16.17 | 10.73 | 893.99 | 73.42 | 25.99 | 35.65 | 30.42 |
| 2023/02/17 | 22.62 | 19.56 | 23.97 | 25.65 | 50.08 | 22.68 | 22.97 | 19.21 | 7.58 | 19.68 | 30.55 | 23.02 |
| 2022/02/18 | 22.07 | 21.05 | 20.92 | 29.94 | 40.66 | 12.36 | 20.93 | 14.78 | 11.76 | 8.37 | 27.35 | 26.55 |
| 2021/02/19 | 40.17 | 18.82 | — | 44.49 | 31.95 | 641.48 | 28.92 | 26.72 | 19.62 | 15.09 | 27.89 | 20.18 |
| 2020/02/21 | 17.82 | 17.07 | 41.99 | 38.34 | 16.19 | 16.45 | 25.99 | 20.60 | 11.63 | 19.86 | 33.36 | 52.90 |
| 2019/02/27 | 20.60 | 14.01 | 16.81 | 29.77 | 39.13 | 15.26 | 23.74 | 33.46 | 21.58 | 18.17 | 35.19 | 22.59 |
| 2018/02/16 | 35.47 | 64.06 | 103.55 | 27.25 | — | 22.75 | 268.10 | 61.63 | 9.99 | 28.99 | 37.66 | 155.08 |
| 2017/02/17 | 16.54 | 16.03 | 20.56 | 23.02 | 32.39 | 6.83 | 20.08 | 46.14 | 28.10 | 42.64 | 30.45 | — |
| 2016/02/19 | 17.01 | 15.95 | 64.22 | 17.85 | 33.35 | 6.75 | 18.80 | 31.64 | 26.37 | 60.50 | 26.19 | — |
| 2015/02/20 | 55.08 | 22.96 | 49.80 | 23.69 | 33.06 | 12.85 | 17.15 | 13.94 | 23.03 | 118.44 | 27.26 | — |
| 2014/02/21 | 19.64 | 18.69 | 35.01 | 19.74 | 13.88 | 42.00 | 18.72 | 37.83 | 9.32 | 77.00 | 38.43 | — |
| 2013/03/15 | 11.51 | 15.68 | 30.56 | 17.73 | 14.99 | 25.20 | 19.64 | 20.94 | 13.51 | 21.42 | 22.54 | — |
レポートに基づく: 10-K (報告日: 2024-12-31), 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31).
産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
AbbVie Inc.、 P/E、長期トレンド、産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
| AbbVie Inc. | 製薬、バイオテクノロジー、ライフサイエンス | |
|---|---|---|
| 2025/02/14 | 79.59 | 45.15 |
| 2024/02/20 | 63.84 | 32.80 |
| 2023/02/17 | 22.62 | 20.23 |
| 2022/02/18 | 22.07 | 19.27 |
| 2021/02/19 | 40.17 | 34.89 |
| 2020/02/21 | 17.82 | 21.03 |
| 2019/02/27 | 20.60 | 22.89 |
| 2018/02/16 | 35.47 | 35.21 |
| 2017/02/17 | 16.54 | 20.62 |
| 2016/02/19 | 17.01 | 19.37 |
| 2015/02/20 | 55.08 | 21.40 |
| 2014/02/21 | 19.64 | 19.54 |
| 2013/03/15 | 11.51 | 17.56 |
レポートに基づく: 10-K (報告日: 2024-12-31), 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31).
業界との比較: 医療
AbbVie Inc.、 P/E、長期トレンド、業界との比較: 医療
| AbbVie Inc. | 医療 | |
|---|---|---|
| 2025/02/14 | 79.59 | 37.14 |
| 2024/02/20 | 63.84 | 29.43 |
| 2023/02/17 | 22.62 | 342,408.13 |
| 2022/02/18 | 22.07 | 21.35 |
| 2021/02/19 | 40.17 | 30.75 |
| 2020/02/21 | 17.82 | 21.64 |
| 2019/02/27 | 20.60 | 25.29 |
| 2018/02/16 | 35.47 | 30.93 |
| 2017/02/17 | 16.54 | 21.47 |
| 2016/02/19 | 17.01 | 19.50 |
| 2015/02/20 | 55.08 | 21.56 |
| 2014/02/21 | 19.64 | 18.62 |
| 2013/03/15 | 11.51 | 15.80 |
レポートに基づく: 10-K (報告日: 2024-12-31), 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31).